"I founded PBL Therapeutics because I believe that interferon has the potential to treat cancer like no other pharmaceutical agent I know. Interferon has been disappointing as an anti-cancer agent – not because it isn't powerful enough, but because it is too powerful. We simply need to figure out how to harness its potential. At PBL Therapeutics we are doing just that. How? The only way I know – by challenging conventional wisdom all the way through the discovery and development process."

Sidney Pestka, M.D.
Founder and Chief Scientific Officer